Acute interstitial nephritis after sequential ipilumumab - nivolumab therapy of metastatic melanoma

Thrombotic Microangiopathy, Cancer, and Cancer Drugs

(2015) Hassan Izzedine et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Ipilimumab Granulomatous Interstitial Nephritis

(2015) Bijin Thajudeen et al.   AMERICAN JOURNAL OF THERAPEUTICS

Anti-programmed cell death protein-1/ligand-1 therapy in different cancers

(2015) B Homet Moreno et al.   BRITISH JOURNAL OF CANCER

The role of type I hypersensitivity reaction and IgE-mediated mast cell activation in acute interstitial nephritis

(2015) Ladan Zand et al.   CLINICAL NEPHROLOGY

The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in Melanoma

(2015) Kathleen M. Mahoney et al.   CLINICAL THERAPEUTICS

PD-1/PD-L1 inhibitors

(2015) Joel Sunshine et al.   CURRENT OPINION IN PHARMACOLOGY

New drug toxicities in the onco-nephrology world

(2015) Mark A. Perazella et al.   KIDNEY INTERNATIONAL

Nivolumab in Previously Untreated Melanoma without BRAF Mutation

(2015) Caroline Robert et al.   NEW ENGLAND JOURNAL OF MEDICINE

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

(2015) James Larkin et al.   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy and Safety of Nivolumab in Patients With BRAF V600 Mutant and BRAF Wild-Type Advanced Melanoma

(2015) James Larkin et al.   JAMA Oncology

Acute interstitial nephritis – a reappraisal and update

(2014) Rajeev Raghavan et al.   CLINICAL NEPHROLOGY

Kidney injuries related to ipilimumab

(2014) Hassane Izzedine et al.   INVESTIGATIONAL NEW DRUGS

Nivolumab plus Ipilimumab in Advanced Melanoma

(2013) Jedd D. Wolchok et al.   NEW ENGLAND JOURNAL OF MEDICINE